History of 7,093 patients with lower urinary tract symptoms related to benign prostatic hyperplasia treated with alfuzosin in general in general practice up to 3 years

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

History Of ◽

History of 7,093 Patients with Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia Treated with Alfuzosin in General Practice up to 3 Years

European Urology ◽

10.1159/000020116 ◽

2000 ◽

Vol 37 (2) ◽

pp. 183-190 ◽

Cited By ~ 25

Author(s):

B. Lukacs ◽

J.C. Grange ◽

D. Comet ◽

C. McCarthy

Keyword(s):

General Practice ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

History Of ◽

Safety and Efficacy of Sustained–Release Alfuzosin on Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in 3,095 Spanish Patients Evaluated during General Practice

European Urology ◽

10.1159/000020163 ◽

2000 ◽

Vol 37 (4) ◽

pp. 421-427 ◽

Cited By ~ 16

Author(s):

M. Sánchez-Chapado ◽

M. Guil ◽

V. Alfaro ◽

Ll. Badiella ◽

N. Fernández-Hernando

Keyword(s):

General Practice ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Safety And Efficacy ◽

Urinary Tract Symptoms ◽

1242: Lower Urinary Tract Symptoms Severity and International Prostate Symptom Score Bother Question Correlate with Measures of Erectile and Ejaculatory Dysfunction in Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/s0022-5347(18)35387-4 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 337-337

Author(s):

Raymond C. Rosen ◽

Kevin T. McVary ◽

James Nuckolls ◽

Richard Payne ◽

Allen D. Seftel ◽

...

Keyword(s):

Urinary Tract ◽

Symptom Score ◽

International Prostate Symptom Score ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Ejaculatory Dysfunction ◽

Study of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

Minerva Urologica e Nefrologica ◽

10.23736/s0393-2249.19.03408-8 ◽

2020 ◽

Vol 72 (1) ◽

Cited By ~ 5

Author(s):

Yi Sun ◽

Bo Peng ◽

Guo-Lin Lei ◽

Qiang Wei ◽

Lu Yang

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase 5 ◽

Faculty Opinions recommendation of Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2111965.1706064 ◽

2010 ◽

Author(s):

Peter Gilling ◽

Liam Wilson

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718133721.793486562 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Faculty Opinions recommendation of Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718145684.793486561 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Symptom Score ◽

International Prostate Symptom Score ◽

Lower Urinary Tract ◽

Combined Therapy ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012867.pub2 ◽

2020 ◽

Author(s):

Jae Hung Jung ◽

Karen Ann McCutcheon ◽

Michael Borofsky ◽

Shamar Young ◽

Jafar Golzarian ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Arterial Embolization ◽

Prostatic Hyperplasia ◽

Prostatic Arterial Embolization ◽

Urinary Tract Symptoms ◽

Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia

European Urology Open Science ◽

10.1016/j.euros.2021.02.001 ◽

2021 ◽

Vol 26 ◽

pp. 72-82

Author(s):

Philipp Dahm ◽

Roderick MacDonald ◽

Lauren McKenzie ◽

Jae Hung Jung ◽

Nancy Greer ◽

...

Keyword(s):

Urinary Tract ◽

Minimally Invasive ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Treatment Modalities ◽

Invasive Treatment ◽

Urinary Tract Symptoms ◽

Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Expert Opinion on Drug Metabolism & Toxicology ◽

10.1517/17425255.2.4.609 ◽

2006 ◽

Vol 2 (4) ◽

pp. 609-617 ◽

Cited By ~ 13

Author(s):

Ricardo R Gonzalez ◽

Steven A Kaplan

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽